State Drug Administration Director Jiao Hong Investigates Production and Distribution of New Coronavirus Vaccines and Therapeutic Drugs in Beijing
State Drug Administration Director Jiao Hong 26 in Beijing to investigate and inspect the new coronavirus vaccine and therapeutic drug production and circulation enterprises work. Jiao Hong stressed that always tighten the string of quality and safety, continue to strengthen the production and supply, circulation and use of all aspects, the whole chain of dynamic supervision, and effectively protect the quality and safety of drugs, strong service to the overall situation of epidemic prevention and control.
More Stories
Internet platform opens appointments for domestic live attenuated herpes zoster vaccination
Recently, Changchun BacTech Biotechnology Co., Ltd. announced that the company recently received the Drug Registration Certificate for the live attenuated...
New crown track into the red sea, Pfizer 100 billion revenue is also difficult to sustain
Despite the negative news about the new crown concept products, the increasing cost of innovation, the rise of companies in...
New crown vaccine “one shot a year” is still controversial, China to follow?
Recently, the U.S. Food and Drug Administration (FDA) released its "Updated Proposal to Simplify New Crown Vaccination," saying that in...
When can I get other vaccines after being infected with the new coronavirus? Anhui CDC issues vaccination tips before school starts
Do I need to pay attention to my child's vaccination status before school starts? Recently, due to the new coronavirus...
New crown vaccine sales revenue declined sharply year-on-year Conchino’s 2022 prep loss topped nearly 1 billion yuan
Conxino released a performance forecast in the evening of January 30, expecting that the net profit attributable to owners of...
Jiangxi CDC important reminder!
Why do children need vaccinations? Babies are born with maternal antibodies mainly from their mothers to fight diseases, but as...
Average Rating